Analgesic Activity of Hexaazaisowurtzitane Derivatives
Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,0 3, 11 ,0 5, 9 ] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (a...
Gespeichert in:
Veröffentlicht in: | Bulletin of experimental biology and medicine 2019-02, Vol.166 (4), p.461-465 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 465 |
---|---|
container_issue | 4 |
container_start_page | 461 |
container_title | Bulletin of experimental biology and medicine |
container_volume | 166 |
creator | Krylova, S. G. Povet’eva, T. N. Zueva, E. P. Suslov, N. I. Amosova, E. N. Razina, T. G. Lopatina, K. A. Rybalkina, O. Yu Nesterova, Yu. V. Afanas’eva, O. G. Kiseleva, E. A. Sysolyatin, S. V. Kulagina, D. A. Zhdanov, V. V. |
description | Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,0
3, 11
,0
5, 9
] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals. |
doi_str_mv | 10.1007/s10517-019-04372-9 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2184539914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A594318027</galeid><sourcerecordid>A594318027</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-4bb5302ebc44b6a88d2d2968948a63b23a88d30d9c8ffb36abfafef1c69d2e7b3</originalsourceid><addsrcrecordid>eNp9kV1LHDEYhUNpqevHH_BCFoTizWi-ZpJcLvbDguCNXock82aNzE5sktHqr2_WtbUWKbkIefOcw3s4CO0TfEwwFieZ4JaIBhPVYM4EbdQ7NCOtYI2klLxHM1yphkspt9B2zjfrJ-7IR7TFsJBSMDVD3WI0wxJycPOFK-EulId59PMz-GnMowk53k-pPIZiRph_hhTuTIUg76IP3gwZ9p7vHXT19cvl6VlzfvHt--nivHFcsNJwa1uGKVjHue2MlD3tqeqk4tJ0zFK2HjHcKye9t6wz1hsPnrhO9RSEZTvoaON7m-KPCXLRq5AdDEPdJ05ZUyJ5y5QivKKH_6A3cUo13RPFFO2wbF-opRlAh9HHkoxbm-pFqzgjElNRqeM3qHp6WAUXR_Chzl8JPv0luAYzlOsch6mEOObXIN2ALsWcE3h9m8LKpAdNsF63qjet6tqqfmpVqyo6eI422RX0fyS_a6wA2wC5fo1LSC_Z_2P7CxlZqlg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2183926085</pqid></control><display><type>article</type><title>Analgesic Activity of Hexaazaisowurtzitane Derivatives</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Krylova, S. G. ; Povet’eva, T. N. ; Zueva, E. P. ; Suslov, N. I. ; Amosova, E. N. ; Razina, T. G. ; Lopatina, K. A. ; Rybalkina, O. Yu ; Nesterova, Yu. V. ; Afanas’eva, O. G. ; Kiseleva, E. A. ; Sysolyatin, S. V. ; Kulagina, D. A. ; Zhdanov, V. V.</creator><creatorcontrib>Krylova, S. G. ; Povet’eva, T. N. ; Zueva, E. P. ; Suslov, N. I. ; Amosova, E. N. ; Razina, T. G. ; Lopatina, K. A. ; Rybalkina, O. Yu ; Nesterova, Yu. V. ; Afanas’eva, O. G. ; Kiseleva, E. A. ; Sysolyatin, S. V. ; Kulagina, D. A. ; Zhdanov, V. V.</creatorcontrib><description>Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,0
3, 11
,0
5, 9
] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-019-04372-9</identifier><identifier>PMID: 30788739</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Acetic acid ; Analgesia ; Analgesics ; Analgesics - therapeutic use ; Animals ; Anti-inflammatory agents ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Chronic pain ; Disease Models, Animal ; Dodecane ; Gastric mucosa ; Gastric Mucosa - drug effects ; Internal Medicine ; Laboratory Medicine ; Male ; Mice ; Naloxone ; Naloxone - therapeutic use ; Opioid receptors ; Organic acids ; Pain - drug therapy ; Pain - physiopathology ; Pain management ; Pain Measurement - methods ; Pain perception ; Pathology ; Psychology ; Resveratrol ; Steroidal anti-inflammatory agents ; Tropism</subject><ispartof>Bulletin of experimental biology and medicine, 2019-02, Vol.166 (4), p.461-465</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>COPYRIGHT 2019 Springer</rights><rights>Bulletin of Experimental Biology and Medicine is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-4bb5302ebc44b6a88d2d2968948a63b23a88d30d9c8ffb36abfafef1c69d2e7b3</citedby><cites>FETCH-LOGICAL-c473t-4bb5302ebc44b6a88d2d2968948a63b23a88d30d9c8ffb36abfafef1c69d2e7b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10517-019-04372-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10517-019-04372-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30788739$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krylova, S. G.</creatorcontrib><creatorcontrib>Povet’eva, T. N.</creatorcontrib><creatorcontrib>Zueva, E. P.</creatorcontrib><creatorcontrib>Suslov, N. I.</creatorcontrib><creatorcontrib>Amosova, E. N.</creatorcontrib><creatorcontrib>Razina, T. G.</creatorcontrib><creatorcontrib>Lopatina, K. A.</creatorcontrib><creatorcontrib>Rybalkina, O. Yu</creatorcontrib><creatorcontrib>Nesterova, Yu. V.</creatorcontrib><creatorcontrib>Afanas’eva, O. G.</creatorcontrib><creatorcontrib>Kiseleva, E. A.</creatorcontrib><creatorcontrib>Sysolyatin, S. V.</creatorcontrib><creatorcontrib>Kulagina, D. A.</creatorcontrib><creatorcontrib>Zhdanov, V. V.</creatorcontrib><title>Analgesic Activity of Hexaazaisowurtzitane Derivatives</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,0
3, 11
,0
5, 9
] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals.</description><subject>Acetic acid</subject><subject>Analgesia</subject><subject>Analgesics</subject><subject>Analgesics - therapeutic use</subject><subject>Animals</subject><subject>Anti-inflammatory agents</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Chronic pain</subject><subject>Disease Models, Animal</subject><subject>Dodecane</subject><subject>Gastric mucosa</subject><subject>Gastric Mucosa - drug effects</subject><subject>Internal Medicine</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Mice</subject><subject>Naloxone</subject><subject>Naloxone - therapeutic use</subject><subject>Opioid receptors</subject><subject>Organic acids</subject><subject>Pain - drug therapy</subject><subject>Pain - physiopathology</subject><subject>Pain management</subject><subject>Pain Measurement - methods</subject><subject>Pain perception</subject><subject>Pathology</subject><subject>Psychology</subject><subject>Resveratrol</subject><subject>Steroidal anti-inflammatory agents</subject><subject>Tropism</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kV1LHDEYhUNpqevHH_BCFoTizWi-ZpJcLvbDguCNXock82aNzE5sktHqr2_WtbUWKbkIefOcw3s4CO0TfEwwFieZ4JaIBhPVYM4EbdQ7NCOtYI2klLxHM1yphkspt9B2zjfrJ-7IR7TFsJBSMDVD3WI0wxJycPOFK-EulId59PMz-GnMowk53k-pPIZiRph_hhTuTIUg76IP3gwZ9p7vHXT19cvl6VlzfvHt--nivHFcsNJwa1uGKVjHue2MlD3tqeqk4tJ0zFK2HjHcKye9t6wz1hsPnrhO9RSEZTvoaON7m-KPCXLRq5AdDEPdJ05ZUyJ5y5QivKKH_6A3cUo13RPFFO2wbF-opRlAh9HHkoxbm-pFqzgjElNRqeM3qHp6WAUXR_Chzl8JPv0luAYzlOsch6mEOObXIN2ALsWcE3h9m8LKpAdNsF63qjet6tqqfmpVqyo6eI422RX0fyS_a6wA2wC5fo1LSC_Z_2P7CxlZqlg</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Krylova, S. G.</creator><creator>Povet’eva, T. N.</creator><creator>Zueva, E. P.</creator><creator>Suslov, N. I.</creator><creator>Amosova, E. N.</creator><creator>Razina, T. G.</creator><creator>Lopatina, K. A.</creator><creator>Rybalkina, O. Yu</creator><creator>Nesterova, Yu. V.</creator><creator>Afanas’eva, O. G.</creator><creator>Kiseleva, E. A.</creator><creator>Sysolyatin, S. V.</creator><creator>Kulagina, D. A.</creator><creator>Zhdanov, V. V.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20190201</creationdate><title>Analgesic Activity of Hexaazaisowurtzitane Derivatives</title><author>Krylova, S. G. ; Povet’eva, T. N. ; Zueva, E. P. ; Suslov, N. I. ; Amosova, E. N. ; Razina, T. G. ; Lopatina, K. A. ; Rybalkina, O. Yu ; Nesterova, Yu. V. ; Afanas’eva, O. G. ; Kiseleva, E. A. ; Sysolyatin, S. V. ; Kulagina, D. A. ; Zhdanov, V. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-4bb5302ebc44b6a88d2d2968948a63b23a88d30d9c8ffb36abfafef1c69d2e7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acetic acid</topic><topic>Analgesia</topic><topic>Analgesics</topic><topic>Analgesics - therapeutic use</topic><topic>Animals</topic><topic>Anti-inflammatory agents</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Chronic pain</topic><topic>Disease Models, Animal</topic><topic>Dodecane</topic><topic>Gastric mucosa</topic><topic>Gastric Mucosa - drug effects</topic><topic>Internal Medicine</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Mice</topic><topic>Naloxone</topic><topic>Naloxone - therapeutic use</topic><topic>Opioid receptors</topic><topic>Organic acids</topic><topic>Pain - drug therapy</topic><topic>Pain - physiopathology</topic><topic>Pain management</topic><topic>Pain Measurement - methods</topic><topic>Pain perception</topic><topic>Pathology</topic><topic>Psychology</topic><topic>Resveratrol</topic><topic>Steroidal anti-inflammatory agents</topic><topic>Tropism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krylova, S. G.</creatorcontrib><creatorcontrib>Povet’eva, T. N.</creatorcontrib><creatorcontrib>Zueva, E. P.</creatorcontrib><creatorcontrib>Suslov, N. I.</creatorcontrib><creatorcontrib>Amosova, E. N.</creatorcontrib><creatorcontrib>Razina, T. G.</creatorcontrib><creatorcontrib>Lopatina, K. A.</creatorcontrib><creatorcontrib>Rybalkina, O. Yu</creatorcontrib><creatorcontrib>Nesterova, Yu. V.</creatorcontrib><creatorcontrib>Afanas’eva, O. G.</creatorcontrib><creatorcontrib>Kiseleva, E. A.</creatorcontrib><creatorcontrib>Sysolyatin, S. V.</creatorcontrib><creatorcontrib>Kulagina, D. A.</creatorcontrib><creatorcontrib>Zhdanov, V. V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krylova, S. G.</au><au>Povet’eva, T. N.</au><au>Zueva, E. P.</au><au>Suslov, N. I.</au><au>Amosova, E. N.</au><au>Razina, T. G.</au><au>Lopatina, K. A.</au><au>Rybalkina, O. Yu</au><au>Nesterova, Yu. V.</au><au>Afanas’eva, O. G.</au><au>Kiseleva, E. A.</au><au>Sysolyatin, S. V.</au><au>Kulagina, D. A.</au><au>Zhdanov, V. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analgesic Activity of Hexaazaisowurtzitane Derivatives</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>166</volume><issue>4</issue><spage>461</spage><epage>465</epage><pages>461-465</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><abstract>Pronounced analgesic activity of the innovative compound 4-(3,4-dibromthiophencarbonyl)-2,6,8,12-tetraacethyl-2,4,6,8,10,12hexaazatetracyclo[5,5,0,0
3, 11
,0
5, 9
] dodecane (thiowurtzine) was observed in the thermal nociceptive hot plate test and in the acute visceral and somatic deep pain model (acetic acid writhing test). In these experimental models, naloxone-sensitive thiowurtzine-induced analgesia was revealed. The absence of tropism to peripheral opioid receptors in the acetic acid writhing test was demonstrated using naloxone methiodide. Course administration of low-toxic thiowurtzine in effective doses was not associated with ulcerogenic damage to the gastric mucosa in experimental animals.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>30788739</pmid><doi>10.1007/s10517-019-04372-9</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-4888 |
ispartof | Bulletin of experimental biology and medicine, 2019-02, Vol.166 (4), p.461-465 |
issn | 0007-4888 1573-8221 |
language | eng |
recordid | cdi_proquest_miscellaneous_2184539914 |
source | MEDLINE; SpringerLink Journals |
subjects | Acetic acid Analgesia Analgesics Analgesics - therapeutic use Animals Anti-inflammatory agents Biomedical and Life Sciences Biomedicine Cell Biology Chronic pain Disease Models, Animal Dodecane Gastric mucosa Gastric Mucosa - drug effects Internal Medicine Laboratory Medicine Male Mice Naloxone Naloxone - therapeutic use Opioid receptors Organic acids Pain - drug therapy Pain - physiopathology Pain management Pain Measurement - methods Pain perception Pathology Psychology Resveratrol Steroidal anti-inflammatory agents Tropism |
title | Analgesic Activity of Hexaazaisowurtzitane Derivatives |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T06%3A44%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analgesic%20Activity%20of%20Hexaazaisowurtzitane%20Derivatives&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Krylova,%20S.%20G.&rft.date=2019-02-01&rft.volume=166&rft.issue=4&rft.spage=461&rft.epage=465&rft.pages=461-465&rft.issn=0007-4888&rft.eissn=1573-8221&rft_id=info:doi/10.1007/s10517-019-04372-9&rft_dat=%3Cgale_proqu%3EA594318027%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2183926085&rft_id=info:pmid/30788739&rft_galeid=A594318027&rfr_iscdi=true |